Opioid agonists modify breast cancer cell proliferation by blocking cells to the G2/M phase of the cycle: Involvement of cytoskeletal elements

Journal of Cellular Biochemistry

Volumn 73, Issue 2, 1999, Pages 204-211

  Panagiotou, Simone ^a   Bakogeorgou, Efstathia ^c   Papakonstanti, Evangelia ^c   Hatzoglou, Anastassia ^b,c   Wallet, France ^a   Dussert, Christophe ^a   Stournaras, Christos ^c   Martin, Pierre Marie ^a   Castanas, Elias ^c  

^a CJF 93 11   (France)

^b INSERM   (France)

^c UNIVERSITY OF CRETE   (Greece)

Author keywords

Breast cancer cells (T47D); Cell cycle; Cell proliferation; Cytoskeleton (actin, tubulin); Opioids

Indexed keywords

ACTIN; CYTOSKELETON PROTEIN; DIPRENORPHINE; ETHYLKETAZOCINE; ETORPHINE; OPIATE AGONIST; OPIATE ANTAGONIST; OPIATE RECEPTOR; TUBULIN;

ARTICLE; BINDING AFFINITY; BREAST CANCER; CANCER CELL; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOSKELETON; DOSE RESPONSE; DRUG RECEPTOR BINDING; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ACTINS; ANALGESICS, OPIOID; BREAST NEOPLASMS; CYTOSKELETON; ETHYLKETOCYCLAZOCINE; ETORPHINE; G2 PHASE; HUMANS; MITOSIS; TUMOR CELLS, CULTURED;

EID: 0033134813     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19990501)73:2<204::AID-JCB6>3.0.CO;2-V     Document Type: Article

References (49)

1. Arnal I, Wade RH. 1995. How does Taxol stabilize microtubules? Curr Biol 5:900-908.
2. Bakogeorgou E, Hatzoglou A, Castanas E. 1997. Taxol interacts with opioid binding sites in the T47D human breast cancer cell line. Biochem Biophys Res Commun 235:201-204.
3. Castanas E, Bourhim N, Giraud P, Boudouresque F, Cantau P, Oliver C. 1985a. Interaction of opiates with opioid binding sites in the bovine adrenal medulla. I. Interaction with delta and mu sites. J Neurochem 45:677-687.
4. Castanas E, Bourhim N, Giraud P, Boudouresque F, Cantau P, Oliver C. 1985b. Interaction of opiates with opioid binding sites in the bovine adrenal medulla. II. Interaction with kappa sites. J Neurochem 45:688-699.
5. Colomb E, Kopp F, Spyratos F, Martin P-M. 1989. Cell-cycle studies by multiparametric automatic scanning of topographically preserved cells in culture. Cytometry 10:263-272.
6. Colomb E, Dussert C, Martin P-M. 1991. Nuclear texture parameters as discriminant factors in cell cycle and drug sensitivity studies. Cytometry 12:15-25.
7. Coward P, Wada HG, Falk MS, Chan SDH, Meng F, Akil H, Conklin BR. 1998. Controlling signaling with a specifically designed Gi-coupled receptor. Proc Natl Acad Sci USA 95:352-357.
8. Galloway MM. 1975. Texture analysis using grey level run lengths. Computer Graphics Image Processing 4:172-179.
9. Glasel JA, Agarwal D. 1997. Theoretical analysis of a morphine withdrawal phenotype in a cultured cell line. Life Sci 61:PL305-313.
10. Haralick RM, Shanmugan K, Dinstein I. 1973. Textural feature for image classification. IEEE Trans Systems Man Cytobernetics SMC-3:610-621.
11. Hatzoglou A, Gravanis A, Zoumakis E, Margioris A, Castanas E. 1995a. Identification and characterization of opioid binding sites present in the Ishikawa human endometrial adenocarcinoma cell line. J Clin Endocrinol Metab 80:418-423.
12. Hatzoglou A, Ouafik LH, Bakogeorgou E, Thermos K, Castanas E. 1995b. Morphine cross-reacts with somatostatin receptor SSTR2 in the T47D human breast cancer cell line, and decreases cell proliferation. Cancer Res 65:5632-5636.
13. Hatzoglou A, Bakogeorgou E, Castanas E. 1996a. The anti-proliferative effect of opioid receptor agonists on the T47D human breast cancer cell line, is partially mediated through opioid receptors. Eur J Pharmacol 296:199-207.
14. Hatzoglou A, Bakogeorgou E, Hatzoglou C, Martin PM, Castanas E. 1996b. Antiproliferative and receptor binding properties of alpha-and beta-casomorphins in the T47D human breast cancer cell line. Eur J Pharmacol 310:217-223.
15. Hatzoglou A, Bakogeorgou E, Papakonstanti E, Stournaras C, Emmanouel DS, Castanas E. 1996c. Identification and characterization of opioid and somatostatin binding sites in the opossum kidney (OK) cell line and their effect on growth. J Cell Biochem 63:410-421.
16. Hauser KF, Stiene-Martin A, Mattson MP, Elde RP, Ryan SE, Godleske CC. 1996. mu-Opioid receptor-induced Ca2+ mobilization and astroglial development: Morphine inhibits Dna synthesis and stimulates cellular hypertrophy through a Ca(2+)-dependent mechanism. Brain Res 720:191-203.
17. Ientile R, Ginoprelli T, Cannavo G, Picerno I, Piedimonte G. 1997. Effect of beta-endorphin on cell growth and cell death in human peripheral blood lymphocytes. J Neuroimmunol 80:87-92.
18. Kampa M, Bakogeorgou E, Hatzoglou A, Damianaki A, Martin PM, Castanas E. 1997. Opioid alkaloids and casomorphin peptides decrease the proliferation of prostatic cancer cell lines (LNCaP, PC3 and DU145) through a partial interaction with opioid receptors. Eur J Pharmacol 335:255-265.
19. Kornyei JL, Vertes Z, Oszter A, Kovacs S, Vertes M. 1997. Opioid peptides inhibit the estradiol-induced proliferation of cultured rat uterine cells. Eur J Pharmacol 336: 65-70.
20. Kumar N. 1981. Taxol-induced polymerization of purified tubulin. Mechanism of action. J Biol Chem 250:10435-10441.
21. Law PY, McGinn TM, Campbell KM, Erickson LE, Loh HH. 1997. Agonist activation of delta-opioid receptor but not mu-opioid receptor potentiates fetal calf serum or tyrosine kinase receptor-mediated cell proliferation in a cell-line-specific manner. Mol Pharmacol 51:152-160.
22. Levin RJ, Wu Y, McLaughlin PJ, Zagon IS. 1997. Expression of the opioid growth factor, [Met5]-enkephalin, and the zeta opioid receptor in head and neck squamous cell carcinoma. Laryngoscope 107:335-339.
23. Maneckjee R, Minna JD. 1990. Opioid and nicotine receptors affect growth regulation of human lung cancer cell lines. Proc Natl Acad Sci USA 87:3294-3298.
24. Maneckjee R, Minna JD. 1994. Opioids induce while nicotine suppresses apoptosis in human lung cancer cells. Cell Growth Diff 5:1033-1040.
25. Maneckjee R, Biswas R, Vonderhaar BK. 1990. Binding of opioids to human MCF-7 breast cancer cells and their effects on growth. Cancer Res 50:2234-2238.
26. McLaughlin PJ. 1996. Regulation of DNA synthesis of myocardial and epicardial cells in developing rat heart by [Met5]enkephalin. Am J Physiol 271:R122-129.
27. Mosmann T. 1973. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 65:55-63.
28. Nogales E, Wolf SG, Khan IA, Luduena RF, Downing KH. 1995. Structure of tubulin at 6.5 A and location of the Taxol binding site. Nature 375:424-427.
29. Ordog T, Vertes Z, Vertes M. 1993. Role of endogenous opioids in progesterone antagonism on oestradiol-induced DNA synthesis in the rat uterus. J Steroid Biochem Mol Biol 45:455-457.
30. Panagiotou S, Martin P-M, Castanas E. 1997. Opioid agonists decrease the concentration of steroid receptors in hormone-sensitive breast cancer cell lines. In: 2emes journees of the IFR Jean Roche. Marseille, France.
31. Panagiotou S, Hatzoglou A, Calvo F, Matrin P-M, Castanas E. 1998. Modulation of the estrogen-regulated proteins cathepsin D and pS2 in hormone-sensitive breast cancer cell lines (MCF7 and T47D) by opioid agonists: Evidence for an interaction between the two systems. J Cell Biochem 71:416-428.
32. +/Pi cotransport alters rapidly cytoskeletal protein polymerization dynamics in opossum kidney cells. Biochem J 315:241-247.
33. Papakonstanti EA, Bakogeorgou E, Castanas E, Emmanouel DS, Hartig R, Stournaras C. 1998. Early alterations of actin cytoskeleton in OK cells by opioids. J Cell Biochem 70:60-69.
34. Reisine T, Bell GI. 1993. Molecular biology of opioid receptors. Trends Neurosci 16:506-510.
35. Rowinsky EK, Wright M, Monsarrat B, Lesser GJ, Donnerhower RC. 1993. Taxol: Pharmacology, metabolism and clinical implications. Cancer Surv 17:283-304.
36. Schiff PB, Horwitz SB. 1980. Taxol stabilizes micritubules in mouse fibroblast cells. Proc Natl Acad Sci USA 77:1561-1565.
37. Schiff PB, Fant J, Horwitz SB. 1979. Promotion of microtubule assembly in vitro by taxol. Nature 277:665-667.
38. Sher E, Cesare P, Codignola A, Clementi F, Tarroni P, Pollo A, Magnelli V, Carbone E. 1996. Activation of delta-opioid receptors inhibits neuronal-like calcium channels and distal steps of Ca(2+)-dependent secretion in human small-cell lung carcinoma cells. J Neurosci 16:3672-3684.
39. Sherr CJ. 1996. Cancer cell cycles. Science 274:1672-1677.
40. Symons M. 1996. Rho family GTPases: The cytoskeleton and beyond. Trends Biochem Sci 21:178-181.
41. Venihaki M, Gravanis A, Margioris AN. 1996. Kappa opioids exert a strong antiproliferative effect on PC12 rat pheochromocytoma cells. Peptides 17:413-419.
42. Vertes Z, Melegh G, Vertes M, Kovacs S. 1982. Effect of naloxone and D-met2-pro5-enkephalinamide treatment on the DNA synthesis in the developing rat brain. Life Sci 31:49-54.
43. Vertes Z, Kornyei JL, Kovacs S, Vertes M. 1996. Opioids regulate cell proliferation in the developing rat uterus: Effects during the period of sexual maturation. J Steroid Biochem Mol Biol 59:173-178.
44. Wallet F, Gerard H, Martin P-M, Dussert C. 1996. Towards a new method to in situ study of apoptosis and its relation with cell cycle. Cytometry 25:263-270.
45. Zagon IS, McLaughlin PJ. 1988. Endogenous opioids and the growth regulation of a neural tumor. Life Sci. 43:1313-1318.
46. Zagon IS, McLaughlin PJ, Goodman SR, Rhodes RE. 1987. Opioid receptors and endogenous opioids in diverse human and animal cancers. J Natl Cancer Inst 79:1059-1065.
47. Zagon IS, Gibo DM, McLaughlin PJ. 1991. Zeta (zeta), a growth-related opioid receptor in developing rat cerebellum: Identification and characterization. Brain Res 551: 28-35.
48. Zagon IS, Sassani JW, McLaughlin PJ. 1995. Opioid growth factor modulates corneal epithelial outgrowth in tissue culture. Am J Physiol 268:R942-950.
49. Zagon IS, Hytrek SD, McLaughlin PJ. 1996. Opioid growth factor tonically inhibits human colon cancer cell proliferation in tissue culture. Am J Physiol 271:R511-518.